EU Alzheimer Disease Market Analysis


  • Type: Common Disease Area
  • Published : January 2022
  • Region: Europe
  • Country: Other
  • Report ID : 4997

  • Format: PPT, PDF

EU Alzheimer Disease Market Analysis: Segmented by Therapeutics, Diagnostics – Growth, Market Size, Future Prospects & Competitive Analysis, 2020 – 2028

SKU: 4997 Categories: ,

Report Description of the EU Alzheimer Disease Market Analysis

Research Scope and Assumption

  • The report provides the market value for the base year 2020 and a yearly forecast up to 2028 in terms of revenue (USD billion)
  • The key industry dynamics, regulatory scenario, reimbursement scenario, major market trends, and drug markets are evaluated to understand their impacts on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis
  • We have used the combination of top-down and bottom-up approach for market sizing, analyzing key regional markets, dynamics, and trends for various solutions, services, and end uses
  • All market estimates and forecasts have been validated through primary interviews with the Key Industry Players (KIPs) and secondary analysis
  • Inflation has not been accounted for in order to estimate and forecast the market
  • Numbers may not add up due to rounding off

Reason to buy the report:

  • Facilitate decision-making based on strong current and forecast data for EU Alzheimer Disease Market Analysis
  • Develop strategies based on the latest regulatory framework
  • Strategically analyze micro-markets with respect to individual growth trends, future prospects, and their contribution to the market
  • Analyze competitive developments such as expansions, investments, mergers & acquisitions, new product developments, and research & developments in the EU Alzheimer Disease  Market  Analysis
  • Analyze the opportunities in the market for stakeholders and draw a competitive landscape for market leaders
  • To strategically profile key players and comprehensively analyze their market shares and core competencies
  • We have technically sound team which do a deep dive research and also provide strategy based consulting analysis

EU Alzheimer Disease Market Analysis Executive Summary

Alzheimer’s disease (AD) is the most common reason of progressive dementia in the elderly population. There has been an exponential rise in the number of cases of Alzheimer’s disease worldwide emphasizing the necessity for developing an effective treatment.

Market Size and Key Findings

The EU Alzheimer Disease Market Analysis size stood at around USD xx billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of 5.75% during the forecast period.

The Alzheimer’s disease therapeutics and diagnostics market in Europe is expected to progress with 5.75% of CAGR over the forecast years 2021-2028.

Market Dynamics

Market Growth Drivers Analysis

There is an increasing in the demand for Alzheimer’s therapeutics and diagnostics. Population aging across the region is a major factor driving the market for Alzheimer’s therapeutics and diagnostics. Rising life expectancy is contributing to quick increases in number of aged population, and is associated with increased prevalence of chronic diseases like dementia.

Market Restraints

Therapies for AD offer temporary and uncertain improvements in the well-being of individuals, and none of the approved drugs can modify the course of the disease advancement. Thus, the magnitude of the affected population and lack of suitable and effective treatment offers an incredible opportunity for drug manufacturers. However, identification of the primary reasons and mechanisms involved in AD are is limited. Drug manufacturers have been unable to validate significant clinical benefits of treatment for a numerous of new compounds due to strict regulations.

COVID-19 impact on “EU Alzheimer Disease Market”

Sudden outbreak of the COVID-19 pandemic had led to the implementation of stringent lockdown regulations across several nations resulting in disruptions in import and export activities of Alzheimer’s Disease Therapeutics and Diagnostics. COVID-19 can affect the economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.

Competitive Landscape

Key Players

Some of the key players in the market include, Pfizer Inc, Novartis AG, Merck & Co Inc, F. Hoffmann-La Roche, Lupin Limited, etc.

Products in Pipeline

  • In 2020, the FDA approved 53 new drugs across all therapeutic categories. Four of these were agents administered as part of imaging procedures including flortaucipir (Tauvid) to be used with PET imaging of the brain to estimate the density and distribution of aggregated tau neurofibrillary tangles in adult patients with cognitive impairment who are being evaluated for AD.

Notable Recent Deals

  1. Hoffmann-La Roche Ltd (Roche or ‘the company’) develops and commercializes innovative therapeutic and diagnostic products. The company undertakes research, along with manufacturing products in several therapeutic areas like neuroscience, ophthalmology, immunology, oncology, and immunology. The company has operations in North America, Asia, Africa, Oceania, Australia, Europe, and Latin America, and is headquartered in Basel, Switzerland.

Healthcare Policies and Regulatory Landscape

Policy changes and Reimbursement scenario

There are around 25 active clinical trials in the UK, under development for Alzheimer’s disease, according to the National Clinical Trials Registry (NCT). Such factors are projected to contribute to the UK’s market growth. In Italy, the aging population of 13.93 million is estimated to reach 16.46 million by 2030. This is set to prompt the government to take the lead in preparing effective drugs. Currently, there are 16 active trials for Alzheimer’s disease as per the NCT. Moreover, according to Alzheimer Europe, an NGO, Italy launched the ‘Interceptor Project’ in December 2017 to identify people prone to Alzheimer’s disease. With the existing research-conducive public policy frameworks, the market in Italy is set to grow in the coming years.

1. Report Description of the EU Alzheimer Disease Market Analysis
1.1 Research Scope and Assumption
1.2 Objective of the study
1.3 Research Methodology
1.4 Reason to buy the report
2. EU Alzheimer Disease Market Analysis Executive Summary
2.1 EU Alzheimer Disease Market Analysis – Industry Snapshot & key buying criteria, 2020-2028
2.2 Market Size, Growth Prospects and Key findings
3. Market Dynamics of EU Alzheimer Disease Market Analysis
3.1 Market Growth Drivers Analysis
3.1.1 Increasing in the demand for Alzheimer’s therapeutics and diagnostics
3.1.2 Increases in number of aged population
3.1.3 Rising life expectancy
3.2 Market Restraints Analysis
3.2.1 Lack of suitable and effective treatment
3.2.2 Identification of the primary mechanisms involved in AD are is limited
3.3 Covid-19 Market Impact Analysis
4. EU Alzheimer Disease Market Segmentation
4.1 By Therapeutics:
4.1.1 Drugs
4.1.2 Disease stage
4.1.3 Generic and branded
4.2 By Diagnostics:
4.2.1 Lumbar Puncture Test
4.2.2 Positron Emission Tomography
4.2.3 Electroencephalography
4.2.4 Magnetic Resonance Imaging
4.2.5 Computed Tomography
4.2.6 Blood Test
4.2.7 Other Diagnostics
5. EU Alzheimer Disease Market Share
5.1 Market Analysis, Insights and Forecast – By Revenue
6. Competitive Landscape
6.1 Major Top Market Players
6.2 Products in Pipeline
6.3 R&D Initiatives Alzheimer Disease Market
6.4 Notable recent deals in Alzheimer Disease Market
6.4.1 Joint Ventures
6.4.2 Partnerships
6.4.3 Mergers & Acquisitions
6.4.4 Strategic divestments
7. Key Company Profiles
7.1 Allergan Plc. (Acquired By Abbvie) Company overview
Product & Services, Strategies & Financials
7.2 Amarantus Bioscience Holdings Inc. Company overview
Product & Services, Strategies & Financials
7.3 Baxter International Inc. Company overview
Product & Services, Strategies & Financials
7.4 Biogen Inc. Company overview
Product & Services, Strategies & Financials
7.5 Cognoptix Inc. Company overview
Product & Services, Strategies & Financials
7.6 Eli Lilly & Company overview
Product & Services, Strategies & Financials
7.7 F. Hoffmann-la Roche company overview
Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape
8.1 Policy changes and Reimbursement scenario
8.2 Government Initiatives / Intervention programs
9. Factors Driving Future Growth
9.1 New Trends and Development of Alzheimer Disease market
9.2 Future Opportunities
10. Strategic Recommendations

EU Alzheimer Disease Market Analysis Segmentation

By Therapeutics:

Based on Therapeutics, the market is segmented into therapeutics by drugs, by disease stage, by generic and branded.

Therapeutics by Drugs

  • Marketed Drugs
  • Pipeline Drugs

Therapeutics by Disease Stage

  • Late Stage: Severe ad
  • Early/Middle Stage: Mild to Moderate ad
  • Prodromal Stage

Therapeutics by Generic and Branded

  • Branded
  • Generic

By Diagnostics:

On the basis of Diagnostics, the Alzheimer Market is segmented on Lumbar Puncture Test, Positron Emission Tomography, Electroencephalography, Magnetic Resonance Imaging, Computed Tomography, Blood Test and Other Diagnostics.

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.

    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements